Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.94M Sell
58,714
-463
-0.8% -$53.4K 1.41% 23
2026
Q1
$7.07M Buy
59,177
+400
+0.7% +$52.5K 1.54% 24
2025
Q4
$8M Buy
58,777
+868
+1% +$125K 1.61% 22
2025
Q3
$8.54M Sell
57,909
-1,090
-2% -$151K 1.75% 24
2025
Q2
$7.63M Buy
58,999
+1,094
+2% +$132K 1.61% 21
2025
Q1
$6.92M Buy
57,905
+1,295
+2% +$160K 1.53% 22
2024
Q4
$6.57M Buy
56,610
+1,053
+2% +$133K 1.38% 24
2024
Q3
$7.5M Sell
55,557
-1
-0% -$134 1.63% 24
2024
Q2
$7.54M Sell
55,558
-305
-0.5% -$41.5K 1.72% 22
2024
Q1
$7.22M Buy
55,863
+872
+2% +$105K 1.71% 22
2023
Q4
$6.29M Sell
54,991
-429
-0.8% -$42.8K 1.63% 23
2023
Q3
$5.04M Sell
55,420
-816
-1% -$84.2K 1.46% 24
2023
Q2
$6.33M Sell
56,236
-2,298
-4% -$243K 1.67% 23
2023
Q1
$6.13M Sell
58,534
-1,190
-2% -$124K 1.65% 22
2022
Q4
$6.6M Buy
59,724
+396
+0.7% +$41.5K 1.91% 20
2022
Q3
$5.18M Sell
59,328
-1,715
-3% -$156K 1.54% 29
2022
Q2
$4.77M Buy
61,043
+4,550
+8% +$376K 1.5% 27
2022
Q1
$4.82M Buy
56,493
+2,832
+5% +$271K 1.29% 32
2021
Q4
$6.43M Buy
53,661
+1,063
+2% +$132K 1.4% 31
2021
Q3
$6.5M Buy
52,598
+261
+0.5% +$33.6K 1.56% 29
2021
Q2
$6.28M Buy
52,337
+2,160
+4% +$247K 1.58% 29
2021
Q1
$5.28M Sell
50,177
-3,192
-6% -$324K 1.51% 33
2020
Q4
$5.43M Buy
53,369
+391
+0.7% +$36.8K 1.62% 32
2020
Q3
$4.46M Sell
52,978
-16,213
-23% -$1.26M 1.61% 31
2020
Q2
$4.5M Sell
69,191
-2,770
-4% -$183K 1.7% 30
2020
Q1
$4.69M Sell
71,961
-182
-0.3% -$14.3K 2.13% 29
2019
Q4
$5.68M Buy
72,143
+4,388
+6% +$342K 1.76% 30
2019
Q3
$5.39M Buy
67,755
+11,361
+20% +$893K 1.84% 27
2019
Q2
$4.72M Sell
56,394
-1,575
-3% -$125K 1.73% 29
2019
Q1
$4.58M Sell
57,969
-208
-0.4% -$15.2K 1.73% 28
2018
Q4
$3.88M Sell
58,177
-1,776
-3% -$123K 1.75% 28
2018
Q3
$4.79M Buy
59,953
+10
+0% +$747 1.87% 22
2018
Q2
$0 Sell
59,943
-2,899
-5% -$210K ﹤0.01% 68
2018
Q1
$4.83M Buy
62,842
+720
+1% +$53.2K 1.57% 25
2017
Q4
$4.24M Buy
+62,122
New +$4.12M 1.37% 27

Other funds holding XYL

Fulcrum Capital's XYL Position: Q2 2026 in Review

Fulcrum Capital reduced its Xylem (XYL) stake by 0.78% in Q2 2026, selling an estimated $53.4K and leaving 58,714 shares worth $6.94M. The position accounts for 1.41% of the portfolio, ranked #23.

Fulcrum Capital first reported a position in XYL in Q4 2017 and has held it in 35 quarters since. The position peaked at $8.54M in Q3 2025. 1,092 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Fulcrum Capital held 58,714 shares of Xylem worth $6.94M as of Q2 2026.
  • Fulcrum Capital sold 463 Xylem shares in Q2 2026, an estimated $53.4K.
  • Xylem made up 1.41% of Fulcrum Capital's portfolio in Q2 2026, its #23 holding.
  • Fulcrum Capital first reported a position in Xylem in Q4 2017 and has held it in 35 quarters since.
  • Fulcrum Capital's Xylem position peaked at $8.54M in Q3 2025.
  • 1,092 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Fulcrum Capital's 13F filing for Q2 2026, filed 21 Jul 2026.